510(k) Report

FDA applicant

Biosite Incorporated

San Diego, CA46 decisions1990–201035 recalls

FDA records 46 decisions for Biosite Incorporated (San Diego, CA) from 1990 to 2010: 45 510(k) clearances and 1 De Novo grant. Most are in product codes NBC (Test, Natriuretic Peptide) and DKZ (Enzyme Immunoassay, Amphetamine). Its devices cite 42 predicates, 25 of them its own earlier devices. 35 recalls are linked to its devices, 11 Class I.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, clinical chemistry panel, where it files most

How often FDA has decided Biosite Incorporated’s devices, and how often a recall has named them.

FDA decisions per year

2in 2010

2007: 32008: 12009: 12010: 2
2007high 3 (2007) · low 0 (2011)2026

2026 so far, outlined.

Recalls per year

1in 2023

2007: 12008: 12009: 52010: 12011: 22012: 9, 4 Class I2013: 12014: 7, 4 Class I2016: 3, 2 Class I2017: 12019: 12020: 22023: 1, 1 Class I
2007high 9 (2012) · low 0 (2015)2026

Class I Class II/III not classified

FIG. 1 — Biosite Incorporated by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Biosite Incorporated’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report